
Processa Pharmaceuticals, Inc.
PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-10-0216:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-039220 |
| 2024-08-2808:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034115 |
| 2024-08-1316:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031622 |
| 2024-07-3008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-029514 |
| 2024-07-1708:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-028093 |
| 2024-07-0219:44 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-025884 |
| 2024-05-2116:13 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-020883 |
| 2024-05-1016:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018648 |
| 2024-04-2916:30 ET | DEF 14A | Proxy statementPeriod 2024-04-29 | 0001493152-24-016998 |
| 2024-04-1108:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-014278 |
| 2024-04-0412:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-013132 |
| 2024-03-2916:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-011976 |
| 2024-02-2117:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-007444 |
| 2024-02-0608:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-005029 |
| 2024-01-3010:46 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004251 |
| 2024-01-2508:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-003705 |
| 2024-01-2218:08 ET | S-1/A | Registration statement, amended | 0001493152-24-003101 |
| 2024-01-1908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-002983 |
| 2024-01-1808:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-002835 |
| 2024-01-0816:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-001713 |
| 2023-12-2908:55 ET | S-1 | Registration statement | 0001493152-23-046483 |
| 2023-12-1909:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-045362 |
| 2023-12-0517:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-043743 |
| 2023-11-1615:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-041652 |
| 2023-11-1511:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-041422 |
| 2023-11-1316:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040472 |
| 2023-11-1314:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-040439 |
| 2023-10-1609:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-037299 |
| 2023-10-0510:00 ET | DEF 14A | Proxy statementPeriod 2023-10-05 | 0001493152-23-035761 |
| 2023-09-2117:29 ET | 8-K | 3.01 Delisting notice; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-033372 |
| 2023-08-1712:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-029250 |
| 2023-08-1016:16 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027551 |
| 2023-08-0810:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-027122 |
| 2023-06-2916:18 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-022920 |
| 2023-06-2112:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-021934 |
| 2023-05-2414:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-018883 |
| 2023-05-1815:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-018082 |
| 2023-05-1510:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-017001 |
| 2023-05-0821:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-015708 |
| 2023-05-0110:00 ET | DEF 14A | Proxy statementPeriod 2023-05-01 | 0001493152-23-014884 |
| 2023-03-3108:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-009935 |
| 2023-03-3016:01 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-009730 |
| 2023-03-2216:30 ET | 8-K | 3.01 Delisting notice | 0001493152-23-008547 |
| 2023-03-1412:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-007564 |
| 2023-02-1316:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-004481 |
| 2023-02-0608:00 ET | 8-K | 8.01 Other events | 0001493152-23-003631 |
| 2023-01-0909:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-000912 |
| 2022-12-2214:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-036285 |
| 2022-12-1411:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-035400 |
| 2022-11-0816:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-030944 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.